Metastatic Non-Small Cell Lung Cancer Market to Surge with a Potential USD 45 Billion Valuation by 2032, Reveals New Comprehensive Analysis
January 24, 2024 10:28 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Metastatic Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's...
Oncology Nutrition Market Experiences Growth with Rise in Personalized and Immuno-nutrition Trends
January 22, 2024 21:28 ET
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Oncology Nutrition Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The recent comprehensive analysis within...
Anti-Cancer Monoclonal Antibodies Market to Reach $95.99 billion by 2028, with Asia Pacific Emerging as Fastest-Growing Region
January 22, 2024 21:08 ET
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Anti-Cancer MAbS Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The Anti-Cancer Monoclonal Antibodies (MAbs)...
Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
January 16, 2024 17:01 ET
|
Adagene Inc.
- Data from first tranche of MSS CRC patients treated with ADG126 10 mg/kg every three weeks (Q3W) in dose expansion showed clinical benefit including confirmed responses at higher, more frequent and...
Compass Therapeutics Provides Corporate Update
January 05, 2024 08:00 ET
|
Compass Therapeutics
We continue to open clinical sites and enroll patients in COMPANION-002, the Phase 2/3 randomized study of CTX-009 (DLL4 x VEGF-A bispecific antibody) in patients with advanced biliary tract cancer...
Groundbreaking Early-Age Onset Colorectal Cancer Think Tank Aims to Transform Colorectal Cancer Outcomes
November 29, 2023 13:49 ET
|
Fight Colorectal Cancer
Springfield, Mo., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Fight Colorectal Cancer (Fight CRC), a national advocacy organization, is leading a groundbreaking initiative to combat the alarming rise of...
Monoclonal Antibodies Market Size Worth USD 572.62 Billion in 2032 | Emergen Research
November 28, 2023 08:17 ET
|
Emergen Research
Vancouver, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The global monoclonal antibodies market size was USD 204.42 billion in 2022 and is expected to register a revenue CAGR of 10.8% during the forecast...
Dubai Government Grants Insurance Reimbursement for Biomerica’s EZ Detect™ Colorectal Disease Screening Test
September 26, 2023 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that the Dubai government has officially approved insurance reimbursement for the EZ...
Fight Colorectal Cancer Hosts Congressional Black Caucus Panel to Tackle Disparities and Drive Progress
September 21, 2023 13:53 ET
|
Fight Colorectal Cancer
Springfield, Mo., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Colorectal cancer, the second-leading cause of cancer-related deaths in the United States, disproportionately impacts the Black community....
Climb for a Cure Raises $1 Million to Support High-Impact Colorectal Cancer Research
September 06, 2023 13:28 ET
|
Fight Colorectal Cancer
Springfield, Mo., Sept. 06, 2023 (GLOBE NEWSWIRE) -- In an inspiring display of unity, determination, and community support, Fight Colorectal Cancer’s Climb for a Cure event has achieved a...